Share This

Public company info - Innovent Biologics Inc. , 01801.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Innovent Biologics Inc., 01801.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12
Net Cash Flow from Operating Activities -1,852,705 -1,998,399 -167,980 -1,678,199 -1,016,019 -492,270 -362,993
Net Cash Flow from Return on Investments & Servicing of Finance 2,375 72,814 75,470 29,216 -8,063 -20,086 -22,382
　Interest Received 107,259 151,640 121,299 70,532 24,784 4,755 4,217
　Interest Paid -104,884 -78,826 -45,829 -41,316 -32,847 -24,841 -26,599
　Dividend Received 0 0 0 0 0 0 0
　Dividend Paid 0 0 0 0 0 0 0
　Others 0 0 0 0 0 0 0
Taxes (Paid) / Refunded -66,099 -26,444 -139,708 13,726 0 0 0
Net Cash Flow from Investing Activities -1,542,444 -2,849,788 -5,305,887 -2,639,689 834,633 -354,211 -576,296
　Additions to Fixed Assets -913,126 -1,065,634 -739,153 -365,873 -312,739 -90,971 -58,444
　Disposal of Fixed Assets 190 98 38 0 285 0 0
　Increase in Investments -214,601 -2,246,692 -4,518,730 -586,984 -231,402 -790,000 -767,000
　Decrease in Investments 644,770 1,558,901 4,642,246 125,108 1,224,625 800,970 290,148
　Net Cash Flow with Related Parties 178,473 2,000 4,619,560 0 0 0 0
　Others -1,238,150 -1,098,461 -9,309,848 -1,811,940 153,864 -274,210 -41,000
Net Cash Flow before Financing Activities -3,458,873 -4,801,817 -5,538,105 -4,274,946 -189,449 -866,567 -961,671
Net Cash Flow from Financing Activities 2,996,966 5,082,187 4,957,950 2,150,631 4,466,710 114,247 1,666,204
　New Loans 1,080,172 1,463,083 372,178 43,000 287,000 10,000 0
　Loans Repayment -392,738 -278,720 -33,788 -19,336 -5,000 0 0
　Fixed Income/Debt Instruments 0 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0 0
　Equity Financing 2,131,059 3,895,824 0 2,126,967 4,184,710 104,247 1,666,205
　Net Cash Flow with Related Parties 178,473 2,000 4,619,560 0 0 0 0
　Others 0 0 0 0 0 0 -1
Increase(Decrease) in Cash & Cash Equivalents -461,907 280,370 -580,155 -2,124,315 4,277,261 -752,320 704,533
Cash & Cash Equivalents at Beginning of Year 1,359,408 1,276,178 2,425,806 4,524,854 183,761 962,991 236,072
Net Cash Flow due to Change in Exchange Rate/Others 118,664 -197,140 -569,473 25,267 63,832 -26,910 22,386
Cash & Cash Equivalents at End of Year 1,016,165 1,359,408 1,276,178 2,425,806 4,524,854 183,761 962,991
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 1 1 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.